Soleus Capital Management’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-46,000	Closed	-$1.46M	–	121
2023 Q2	$1.46M	Sell	46,000 -109,000	-70%	-$3.47M	0.16%	79
2023 Q1	$3.78M	Buy	+155,000	New	+$3.78M	0.39%	54